An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential. (Q52837476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

title

An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

Franziska Roth-Walter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

Robyn E O'Hehir

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

Erika Jensen-Jarolim

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

author name string

F Felix

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

D Krishnamurthy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

C Stremnitzer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

S R Prickett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

A L Voskamp

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

A Willensdorfer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

K Szalai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

M Weichselbaumer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

1801-1812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

Future therapies for food allergies

18 February 2020

cites work

1 reference

Effect of anti-IgE therapy in patients with peanut allergy

21 January 2018

1 reference

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy

21 January 2018

1 reference

Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study

21 January 2018

1 reference

Inhibition of rBet v 1-induced basophil histamine release with specific immunotherapy -induced serum immunoglobulin G: no evidence that FcgammaRIIB signalling is important

21 January 2018

1 reference

IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB.

21 January 2018

1 reference

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

21 January 2018

1 reference

In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure

21 January 2018

1 reference

21 January 2018

1 reference

Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.

21 January 2018

1 reference

Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy

21 January 2018

1 reference

US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up

21 January 2018

1 reference

Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal

21 January 2018

1 reference

The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry

21 January 2018

1 reference

Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen.

21 January 2018

1 reference

Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation

21 January 2018

1 reference

Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time.

21 January 2018

1 reference

Heating Affects Structure, Enterocyte Adsorption and Signalling, As Well as Immunogenicity of the Peanut Allergen Ara h 2

21 January 2018

1 reference

Effect of heating and glycation on the allergenicity of 2S albumins (Ara h 2/6) from peanut

21 January 2018

1 reference

A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis

21 January 2018

1 reference

Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen

21 January 2018

1 reference

Relevance of IgE binding to short peptides for the allergenic activity of food allergens

21 January 2018

1 reference

Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy.

21 January 2018

1 reference

Colorimetric assay for antifungal susceptibility testing of Aspergillus species

21 January 2018

1 reference

Ara h 2 peptides containing dominant CD4 T-cell epitopes: candidates for a peanut allergy therapeutic.

21 January 2018

1 reference

Ara h 2: crystal structure and IgE binding distinguish two subpopulations of peanut allergic patients by epitope diversity

21 January 2018

1 reference

UCSF Chimera--a visualization system for exploratory research and analysis

21 January 2018

1 reference

Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions

21 January 2018

1 reference

Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge

21 January 2018

1 reference

DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice

21 January 2018

1 reference

Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants

21 January 2018

1 reference

Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors.

21 January 2018

1 reference

Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract

21 January 2018

1 reference

Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis

21 January 2018

1 reference

12 December 2020

The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial

1 reference

12 December 2020

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007

1 reference

12 December 2020

Mechanisms of allergen-specific desensitization

1 reference

12 December 2020

Mechanisms of allergen-specific immunotherapy

1 reference

12 December 2020

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines

1 reference

12 December 2020

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1

1 reference

12 December 2020

Allergenic properties of ovomucoid in man

1 reference

12 December 2020

Identifiers

DOI

10.1111/CEA.12031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23181796 AND SRC:MED&resulttype=core&format=json

18 February 2020

PubMed publication ID

23181796

1 reference